IP Library › Assignment 040068/0687
Patent Assignment
Reel/Frame 040068/0687

Release of Security Interest in Patents

Recorded: 2016-09-12 Pages: 28
Assignor
Assignee
INTERHEALTH NUTRACEUTICALS INCORPORATED
C/O KAINOS CAPITAL, LLC, 2100 MCKINNEY AVENUE, SUITE 1600, DALLAS, TEXAS, 75201
Covered Properties (52)
Treatment Process for Promoting Weight Loss Employing a Substituted DELTA5-Androstene
Application: 07/575,156 →
Treatment Process for Promoting Weight Loss Employing a Substituted DELTA5-Androstene
Patent: 5,296,481 →
Application: 07/867,288 →
Modulation of Immune System with Delta 5 -Androstenes
Patent: 5,292,730 →
Application: 07/922,850 →
Treatment of Immune System with Delta 5-Androstenes
Patent: 5,585,371 →
Application: 08/189,917 →
Up-Regulation of Immune System with Delta 5-Androstenes
Patent: 5,641,766 →
Application: 08/527,746 →
Use of DELTA5 Androstenes in the Treatment of Hiv Wasting Syndrome
Patent: 5,885,977 →
Application: 08/784,856 →
Treatment of Alzheimer's Disease and Modulation of Immune System with Delta 5-Androstenes
Patent: 5,707,983 →
Application: 08/806,541 →
Process for Effecting Allylic Oxidation
Patent: 5,869,709 →
Application: 08/851,939 →
Copper-Catalysed Allylic Oxidation Using Alkyl Hydroperoxide
Patent: 6,252,119 →
Application: 08/901,764 →
Compositions and Methods of Treatment of Neoplastic Diseases and Hypercholesterolemia with Citrus Limonoids and Flavonoids and Tocotrienols
Patent: 6,251,400 →
Application: 08/938,640 →
Memory Enhancement by the Administration of DELTA5-Androstene- 3BETA-Ol-7, 17-Dione and 3 Beta Esters Thereof
Patent: 6,153,606 →
Application: 09/174,235 →
Process for Effecting Allylic Oxidation
Patent: 6,111,118 →
Application: 09/228,902 →
Process for Effecting Allylic Oxidation Using Dicarboxylic Acid Imides and Chromium Reagents
Patent: 6,384,251 →
Application: 09/423,467 →
Hydroxycitric Acid Compositions, Pharmaceutical and Dietary Supplements and Food Products Made Therefrom, and Methods for Their Use in Reducing Body Weight
Patent: 7,927,636 →
Application: 09/463,024 →
Compositions And Methods For Treatment Of Neoplastic Diseases With Combinations Of Limonoids, Flavonoids And Tocotrienols
Patent: 6,239,114 →
Application: 09/481,963 →
Compositions and Methods of Treating,Reducing, and Preventing Cardiovascular Diseases and Disorders with Polymethoxyflavones
Patent: 6,987,125 →
Application: 09/528,488 →
Use of DELTA5-Androstene-3BETA-OL7,17-Dione in the Treatment of Arthritis
Patent: 6,794,374 →
Application: 09/554,951 →
Use of delta 5- androstene -3 beta- ol- 7, 17- dione in the treatment of lupus erythematosus
Patent: 6,372,732 →
Application: 09/554,952 →
Process for Effecting Allylic Oxidation
Patent: 6,686,486 →
Application: 09/639,027 →
Treatment of inflammatory bowel disease by the administration of delta5-androstene-3beta-OL-7,17 dione and metabolizable precursors thereof
Application: 09/665,640 →
Memory by the Administration of DELTA5-Androstene-3BETA-Ol-7,17-Dione and 3BETA Esters
Patent: 6,489,313 →
Application: 09/704,495 →
Method for Diminishing Wrinkles and Fine Lines of the Skin by the Topical Application of DELTA5-Androstene-3BETA-Ol-7, 17 Dione and Metabolizable Precursors Thereof
Patent: 6,399,084 →
Application: 09/799,295 →
Method of Moisturizing the Skin by the Topical Application of DELTA5-Androstene-3BETA-Ol-7,17 Dione and Metabolizable Precursors Thereof
Patent: 6,399,085 →
Application: 09/799,313 →
Treatment of Dermatitis by the Topical Application of DELTA5-Androstene-3BETA-Ol-7,17 Dione and Metabolizable Precursors Thereof
Patent: 6,465,446 →
Application: 09/805,024 →
Method for Producing Biologically Active Products
Patent: 7,083,820 →
Application: 09/964,120 →
Publication: US 2002/0065231
Compositions and Methods of Use for Extracts of Magnoliaceae Plants
Patent: 6,582,735 →
Application: 09/996,254 →
Publication: US 2002/0076456
Use of DELTA5-Androstene-3BETA Ol-7,17-Dione in the Treatment of Lupus Erythematosus
Patent: 6,593,316 →
Application: 10/106,580 →
Publication: US 2002/0160989
Method and Composition for Preventing or Reducing the Symptoms of Insulin Resistance Syndrome
Patent: 7,119,110 →
Application: 10/265,093 →
Publication: US 2003/0133992
Method of Modulating the Basal Metabolic Rate of a Dieting Mammal by Administration of a Metabolic Modulating Agent to the Dieting Mammal
Patent: 7,199,116 →
Application: 10/340,980 →
Publication: US 2004/0138303
Compositions and Methods of Use for Extracts of Magnoliaceae Plants
Patent: 6,814,987 →
Application: 10/423,506 →
Publication: US 2003/0206975
Use of DELTA5-Androstene-3BETA-Ol-7,17-Dione in the Treatment of Lupus Erythematosus
Patent: 6,924,274 →
Application: 10/431,960 →
Publication: US 2004/0048839
Treatment of Chronic Fatigue Syndrome and Fibromyalgia Syndrome
Patent: 7,553,829 →
Application: 10/433,043 →
Publication: US 2004/0038955
Method of achieving accelerated fat loss by administration of a fat loss accelerating agent to a dieting mammal
Application: 10/541,780 →
Publication: US 2006/0217357
Method of achieving accelerated weight loss by administration of a weight loss accelerating agent to a dieting mammal
Application: 10/541,781 →
Publication: US 2006/0135499
Compositions and Methods of Treating, Reducing and Preventing Cardiovascular Diseases and Disorders with Polymethoxyflavones
Patent: 7,683,095 →
Application: 10/854,063 →
Publication: US 2004/0214882
Compositions Incorporating(-)-Hydroxycitric Acid and Related Methods for Promoting Fat Oxidation
Patent: 7,335,651 →
Application: 10/911,095 →
Publication: US 2005/0008722
Method and Composition for Preventing or Reducing the Symptoms of Insulin Resistance Syndrome
Patent: 7,153,877 →
Application: 11/009,266 →
Publication: US 2005/0100614
Hydroxycitric Acid Compositions, Pharmaceutical and Dietary Supplements and Food Products Made Therefrom, and Methods for Their Use in Reducing Body Weight
Patent: 7,943,186 →
Application: 11/209,429 →
Publication: US 2005/0282894
Hydroxycitric Acid Compositions, Pharmaceutical and Dietary Supplements and Food Products Made Therefrom, and Methods for Their Use in Reducing Body Weight
Patent: 7,858,128 →
Application: 11/209,580 →
Publication: US 2005/0282904
Biologically Active Products
Patent: 7,846,487 →
Application: 11/343,013 →
Publication: US 2006/0127494
Composition and Method for Promoting Weight Loss, Fat Loss or Modulation of Metabolic Rate
Application: 11/570,903 →
Nutraceutical Treatments for Diabetic and Non-Diabetic Wound Healing
Patent: 7,887,848 →
Application: 11/809,149 →
Publication: US 2008/0003303
Method for Increasing Serotonin Levels in a Person by Administration of a Composition Incorporating (-)Hydroxycitric Acid, and Related Compositions Thereof
Application: 12/033,419 →
Publication: US 2008/0139657
Trivalent Chromium Compounds, Compositions and Methods of Use
Application: 12/251,310 →
Publication: US 2009/0092560
Collagen Dispersion and Method of Producing Same
Patent: 8,748,499 →
Application: 12/757,698 →
Publication: US 2010/0303898
Use of Delta 5-Androstene-3 Beta-Ol-7,17-Dione in the Treatment of Arthritis
Application: 60/066,197 →
Use of 5-Androstene-3B-Ol-7,I7-Dione in the Treatment of Lupus Erythematosus
Application: 60/066,198 →
Process for Effecting Allylic Oxidation Using Dicarboxylic Acid Imides and Chromium Reagents
Application: 60/078,978 →
Treatment of chronic fatigue syndrome and fibromyalgia synorome by the administration of delta5-androstene-3beta-ol-7,17 dione and metabolizable precursors thereof
Application: 60/250,227 →
Method of achieving accelerated weight loss by administration of a weight loss accelerating agent to a dieting mammal
Application: 60/439,753 →
Method of achieving accelerated fat loss by administration of a fat loss accelerating agent to a dieting mammal
Application: 60/439,816 →
Composition containing 7-oxo DHEA, a source of bioavailable chromium, a source of bioavailable calcium, green tea extract and vitamins C & D, and method of promoting weight loss, fat loss or modulation of a dieting-induced change in basal metabolic rate by administration of the composition
Application: 60/599,469 →
Related Assignments (21)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement Dec 4, 2009
From: HUMANETICS CORPORATION
To: HOPFENSPIRGER, LARRY
Reel/Frame 023594/0680 →
Assignment of Patent Security Agreement Recorded 04/05/07 with Uspto at Reel 019116, Frame 0641 Jan 27, 2012
From: UNICREDIT BANK AG, NEW YORK BRANCH, AS ATTORNEY-IN-FACT FOR HILCO FINANCIAL, LLC (N/K/A 1310 FINANCIAL, LLC) UNDER POA DATED DECEMBER 24, 2008
To: UNICREDIT BANK AG, NEW YORK BRANCH
Reel/Frame 027612/0709 →
Change of Name Nov 2, 2012
From: HARBOR BIOSCIENCES, INC.
To: HARBOR DIVERSIFIED, INC.
Reel/Frame 029227/0929 →
Assignment Jun 4, 2013
From: KGK SYNERGIZE INC.
To: NPI, LLC
Reel/Frame 030555/0767 →
Security Agreement Dec 2, 2013
From: INTERHEALTH NUTRACEUTICALS INCORPORATED
To: MADISON CAPITAL FUNDING LLC (AS ADMINISTRATIVE AGENT)
Reel/Frame 031748/0036 →
Security Interest Mar 17, 2014
From: INTERHEALTH NUTRACEUTICALS INCORPORATED
To: MADISON CAPITAL FUNDING LLC (AS ADMINISTRATIVE AGENT)
Reel/Frame 032456/0710 →
Assignment of Assignor's Interest May 30, 2014
From: CHICK CART, INC.
To: INTERHEALTH NUTRADEUTICALS INCORPORATED
Reel/Frame 032995/0662 →
Assignment of Assignor's Interest Jul 10, 2014
From: LARDY, HENRY A.; SHI, JENNIFER Y.
To: HUMANETICS CORPORATION
Reel/Frame 033283/0315 →
Release of Security Interest Jul 10, 2014
From: HOPFENSPIRGER, LARRY
To: HUMANETICS CORPORATION
Reel/Frame 033293/0475 →
Release of Security Interest Jul 10, 2014
From: HOPFENSPIRGER, LARRY
To: HUMANETICS CORPORATION
Reel/Frame 033300/0527 →
Assignment of Assignor's Interest Aug 27, 2014
From: HUMANETICS CORPORATION
To: INTERHEALTH NUTRACEUTICALS INCORPORATED
Reel/Frame 033645/0212 →
Corrective Assignment to Correct the Receiving Party Name Previously Recorded at Reel: 032995 Frame: 0662. Assignor(S) Hereby Confirms the Assignment. Oct 30, 2014
From: CHICK CART, INC.
To: INTERHEALTH NUTRACEUTICALS INCORPORATED
Reel/Frame 034113/0056 →
Security Interest Apr 23, 2015
From: INTERHEALTH NUTRACEUTICALS INCORPORATED
To: MADISON CAPITAL FUNDING LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 035486/0554 →
Assignment of Assignor's Interest May 8, 2015
From: NPI, LLC
To: INTERHEALTH NUTRACEUTICALS
Reel/Frame 035598/0741 →
Security Interest May 12, 2015
From: INTERHEALTH NUTRACEUTICALS INCORPORATED
To: MADISON CAPITAL FUNDING LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 035649/0040 →
Release and Reassignment of Intellectual Property Security Interests Aug 23, 2016
From: UNICREDIT BANK AG, NEW YORK BRANCH AS SECURED PARTY IN POSSESSION OF THE ASSETS OF HILCO FINANCIAL LLC
To: HUMANETICS CORPORATION; ADVANTRX CORPORATION
Reel/Frame 039784/0922 →
Release of Security Interest Oct 5, 2016
From: MADISON CAPITAL FUNDING LLC
To: INTERHEALTH NUTRACEUTICALS INCORPORATED
Reel/Frame 040234/0538 →
Assignment of Assignor's Interest Aug 8, 2021
From: NEURMEDIX, LLC
To: NEURMEDIX, INC.
Reel/Frame 057116/0362 →
Assignment of Assignor's Interest Aug 8, 2021
From: NEURMEDIX, INC.
To: NEURMEDIX, LLC
Reel/Frame 057116/0336 →
Assignment of Assignor's Interest Aug 8, 2021
From: NEURMEDIX, INC.
To: BIOVIE INC.
Reel/Frame 057116/0451 →
Change of Name Oct 15, 2021
From: INTERHEALTH NUTRACEUTICALS INCORPORATED
To: LONZA CONSUMER HEALTH INC.
Reel/Frame 057828/0594 →